NCT04818567 is a clinical trial in ERCP, Failure, Complications, Cannulation, sponsored by Assiut University.

Who is sponsoring NCT04818567?

NCT04818567 is sponsored by Assiut University.

What condition does NCT04818567 study?

NCT04818567 studies ERCP, Failure, Complications, Cannulation.

Is NCT04818567 still recruiting?

NCT04818567 is currently status unknown. Last updated 29 July 2021.

Last reviewed 2021-07-29 · How we verify

NCT04818567

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Frequency and Causes of Failed Endoscopic Retrograde Cholangio-Pancreatography in AL-Rajhi Endoscopy Unit

Status unknown Last updated 29 July 2021

What this trial tests

trial in ERCP, Failure, Complications, Cannulation in 196 participants. Status unknown.

Timeline

1 August 2021

Primary endpoint
1 May 2022

30 May 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	196
Start date	1 August 2021
Primary completion	1 May 2022
Estimated completion	30 May 2022

Conditions studied

ERCP, Failure, Complications, Cannulation — all drugs for ERCP, Failure, Complications, Cannulation →

Sponsor

Assiut University

Who can join

Adults 6 to 80, any sex, with ERCP, Failure, Complications, Cannulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The failure can be traced backed to operator causes, technical causes and patient causes. the most common etiology is cannulation failure. ERCP complications includes post-ERCP pancreatitis, perforation, bleeding, cholangitis and cholecystitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04818567 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04818567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing